INOVIO Pharmaceuticals is a clinical-stage biotechnology company known for advancing DNA medicine research. Its work is aimed at helping patients by developing therapies for HPV-related disease, cancer and infectious disease, with INO-3107 as its lead candidate for recurrent respiratory papillomatosis.
Institutional Biosafety Committee (IBC)
Compliance program
GSK plcGSK plc is a focused biopharmaceutical company that discovers, develops and delivers medicines and vaccines. Its research and development concentrates on respiratory, immunology and inflammation; oncology; HIV; and infectious diseases, with R&D hubs in the UK, US and Belgium and a network spanning Europe, North America and Asia.PENNSYLVANIA, PA
Iovance Biotherapeutics, IncIovance Biotherapeutics develops and manufactures personalized tumor-infiltrating lymphocyte (TIL) cell therapies for people with cancer. Its 136,000-square-foot Iovance Cell Therapy Center in Philadelphia makes TIL therapy using proprietary processes, including a 22-day Gen 2 process; the company also markets Amtagvi and Proleukin.PHILADELPHIA, PA
Facili Bio LLCFacili Bio LLC uses an AI-powered drug-discovery platform and proprietary computational biology to develop new cancer treatments. The company focuses on difficult areas of oncology, pairing research into patient-specific therapies with clinical studies intended to move promising discoveries toward patients.ALBANY, NY
Duo OncologyFounded by nanoparticle and drug-delivery researchers, Pittsburgh-based Duo Oncology is a clinical-stage biotechnology company developing tumor-activated medicines for cancer treatment. Its lead program, DUO-207, is designed to simplify chemotherapy by concentrating drug activity in tumors while reducing exposure in healthy tissue.PITTSBURGH, PA